Cholecalciferol (VD3) Attenuates L-DOPA-Induced Dyskinesia in Parkinsonian Mice Via Modulation of Microglia and Oxido-Inflammatory Mechanisms

L-DOPA, the gold standard for managing Parkinson's disease (PD) is fraught by motor fluctuations termed L-Dopa-Induced Dyskinesia (LID). LID has very few therapeutic options. Hence, the need for preclinical screening of new interventions. Cholecalciferol (VD3) treatment reportedly improves moto...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nigerian journal of physiological sciences 2022-12, Vol.37 (2), p.175-183
Hauptverfasser:	Bayo-Olugbami, Adedamola, Nafiu, AbdulRazaq Bidemi, Amin, Abdulbasit, Ogundele, Olalekan Michael, Lee, Charles C, Owoyele, Bamidele Victor
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!